WILMINGTON – The trio of companies that emerged from the legacy of E. I. du Pont de Nemours and Company – DuPont, Chemours and Corteva – have reached a settlement worth as much as $4 ...
WILMINGTON – A new state advisory group intends to increase Delaware’s spotlight as a science and technology innovation hub, helping the state remain competitive in the region for growing and relocating companies. The Science & ...
From the earliest scientific advancements made at DuPont more than two centuries ago to the brand-new cancer therapies being developed by Incyte, Delaware has a long history of laboratory-based research and development. As the competition ...
WILMINGTON – The COVID-19 pandemic appears to have killed the deal between DuPont and Delle Donne & Associates that would have seen a large portion of the chemical manufacturing giant’s headquarters campus redeveloped. On Friday ...
WILMINGTON – Pharmaceutical giant AstraZeneca announced May 21 that it will receive upward of $1.2 billion from the federal government to advance work on its COVID-19 vaccine. The Cambridge-based company, which has its U.S. headquarters ...
NEWARK — The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) received a $9 million boost in federal funding while the country looks to the future coronavirus vaccine. NIIMBL, a partnership between federal, university and ...
WILMINGTON – The Delaware Bioscience Association announced Thursday that its president and CEO, Helen Stimson, was departing June 1 in order to take the role of chief operating officer at Adesis Inc., a contract research ...
WILMINGTON — The roster of publicly-held companies physically headquartered in Delaware has increased by one in 2020 as Ashland Global Holdings Inc. – a specialty chemicals company that acquired Hercules in 2008 and already had ...
By Dora Cheatham As my cat makes its way across my computer keyboard for the fifth time this morning, it is redundant to say that the last few weeks our lives have been thrown into ...
WILMINGTON – The Chemours Co. reported late March 3 that it was borrowing $300 million from its revolving credit fund as a precaution in a market rocked by the coronavirus outbreak. The funds from the ...
